Park JC, Han SH, Cho HJ, Byun MS, Yi D, Choe YM, Kang S, Jung ES, Won SJ, Kim EH, Kim YK, Lee DY, Mook-Jung I. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition. Alzheimers Res Ther. 2017 Mar 22;9(1):20. PubMed.
AlzBiomarker Database
Meta-Analysis
Curated Study Data
| Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
|---|---|---|---|---|
| Aβ42 (Plasma) |
AD (43) |
37.5 ± 1.72† pg/mL |
xMAP; INNO-BIA plasma Aβ ; Fujirebio |
McKhann et al., 2011 |
| Aβ42 (Plasma) |
CTRL- CNC (187) |
44.57 ± 1.05† pg/mL |
xMAP; INNO-BIA plasma Aβ ; Fujirebio |
† Mean ± SEM
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.